Suppr超能文献

基于血管造影的微血管阻力指数(IMR)作为一种新型的无压力导丝工具,用于评估急性冠状动脉综合征和稳定型冠状动脉疾病中的冠状动脉微血管功能障碍。

Angiography-derived index of microcirculatory resistance (IMR) as a novel pressure-wire-free tool to assess coronary microvascular dysfunction in acute coronary syndromes and stable coronary artery disease.

机构信息

Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Headley Way, Oxford, OX39DU, UK.

Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.

出版信息

Int J Cardiovasc Imaging. 2021 Jun;37(6):1801-1813. doi: 10.1007/s10554-021-02254-8. Epub 2021 May 5.

Abstract

To investigate the diagnostic accuracy of (1) hyperaemic angiography-derived index of microcirculatory resistance (IMR) in defining coronary microvascular dysfunction (CMD) across patients with acute coronary syndromes (ST-elevation myocardial infarction [STEMI]; non-ST elevation acute coronary syndrome [NSTE-ACS]) and stable chronic coronary syndrome [CCS]) and (2) the accuracy of non-hyperaemic IMR (NH-IMR) to detect CMD in STEMI. 145 patients (STEMI = 66; NSTEMI = 43; CCS = 36) were enrolled. 246 pressure-wire IMR measurements were made in 189 coronary vessels. IMR and NH-IMR was derived using quantitative flow ratio. In patients with STEMI, cardiac magnetic resonance was performed to quantify microvascular obstruction (MVO). IMR was correlated with IMR (overall rho = 0.78, p < 0.0001; STEMI, rho = 0.85 p < 0.0001; NSTE-ACS and rho = 0.72, p < 0.0001; CCS, rho = 0.70, p < 0.0001) and demonstrated good diagnostic performance in predicting high IMR (STEMI AUC = 0.93 [0.88-0.98]; NSTE-ACS AUC = 0.77 [0.63-0.92]; CCS AUC = 0.88 [0.79-0.97]). Agreement between the two indices was evident on Bland Altman analysis. In STEMI, NH-IMR was also well correlated with IMR (rho = 0.64, p < 0.0001), with good diagnostic accuracy in predicting high invasive IMR (AUC = 0.82 [0.74-0.90]). Both IMR (AUC = 0.74 [0.59-0.89]) and NH-IMR (AUC = 0.76 [0.54-0.87]) were significantly associated with MVO in STEMI. In conclusions, IMR is a valid alternative to invasive IMR to detect CMD in patients with acute and stable coronary syndromes, whilst NH-IMR has a good diagnostic accuracy in STEMI where it could become a user-friendly diagnostic tool as it is adenosine-free.

摘要

为了研究(1)在急性冠状动脉综合征(ST 段抬高型心肌梗死[STEMI];非 ST 段抬高型急性冠状动脉综合征[NSTE-ACS])和稳定型慢性冠状动脉综合征[CCS]患者中,基于充血状态的微血管阻力指数(IMR)对冠状动脉微血管功能障碍(CMD)的诊断准确性,以及(2)非充血状态 IMR(NH-IMR)检测 STEMI 中 CMD 的准确性,对 145 名患者(STEMI=66;NSTE-ACS=43;CCS=36)进行了研究。对 189 个冠状动脉进行了 246 次压力导丝 IMR 测量。使用定量血流比来推导 IMR 和 NH-IMR。在 STEMI 患者中,进行心脏磁共振成像以量化微血管阻塞(MVO)。IMR 与 IMR(整体 rho=0.78,p<0.0001;STEMI,rho=0.85,p<0.0001;NSTE-ACS,rho=0.72,p<0.0001;CCS,rho=0.70,p<0.0001)呈相关性,并在预测高 IMR 方面具有良好的诊断性能(STEMI AUC=0.93[0.88-0.98];NSTE-ACS AUC=0.77[0.63-0.92];CCS AUC=0.88[0.79-0.97])。 Bland Altman 分析显示两种指数之间具有良好的一致性。在 STEMI 中,NH-IMR 也与 IMR 高度相关(rho=0.64,p<0.0001),预测高侵入性 IMR 具有良好的诊断准确性(AUC=0.82[0.74-0.90])。在 STEMI 中,IMR(AUC=0.74[0.59-0.89])和 NH-IMR(AUC=0.76[0.54-0.87])均与 MVO 显著相关。总之,IMR 是一种替代有创性 IMR 检测急性和稳定型冠状动脉综合征患者 CMD 的有效方法,而 NH-IMR 在 STEMI 中具有良好的诊断准确性,它可以成为一种方便用户的诊断工具,因为它不含腺嘌呤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验